Attovia director granted 27,000 stock options at $17
Attovia Therapeutics, Inc. reported that director Mitchell Gold received a grant of 27,000 stock options to buy common stock at an exercise price of $17.00 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Attovia Therapeutics, Inc. reported that director Mitchell Gold received a grant of 27,000 stock options to buy common stock at an exercise price of $17.00 per share. The options expire on August 3, 2036. According to the award terms, 25% of the options vest on August 4, 2027, with the remaining options vesting in equal monthly installments over the following 36 months, subject to continued service.
Insider Trade Summary
Grant/Award: 27,000 shares
Grant/Award
1 txn
Insider
GOLD MITCHELL
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 27,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 27,000 contracts (Direct)
Footnotes (1)
- F1. 25% of the options shall vest on August 4, 2027 and the remaining options shall vest in equal monthly installments over the following 36 months, subject to continued service to the Issuer through such dates.
Key Figures
Stock options granted: 27,000 options
Exercise price: $17.00 per share
Options held after grant: 27,000 options
+3 more
6 metrics
Stock options granted
27,000 options
Stock Option (Right to Buy) grant to director Mitchell Gold
Exercise price
$17.00 per share
Conversion or exercise price of the stock option award
Options held after grant
27,000 options
Total derivative securities directly owned following the reported transaction
Expiration date
August 3, 2036
Expiration date of the granted stock options
Initial vesting tranche
25% on August 4, 2027
First portion of options that vest, subject to continued service
Remaining vesting period
36 months
Remaining options vest in equal monthly installments over 36 months
Key Terms
Stock Option (Right to Buy), exercise price, vesting, derivative
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 17.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the options shall vest on August 4, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative financial
"transaction_type: derivative"
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Mitchell Gold report in this Form 4 for ATTO?
Mitchell Gold reported a grant of 27,000 stock options for Attovia Therapeutics (ATTO). These options allow him to buy common stock at a fixed $17.00 exercise price before they expire on August 3, 2036.
What is the exercise price of the new stock options for ATTO?
The granted options have an exercise price of $17.00 per share. This means Mitchell Gold can purchase Attovia Therapeutics common stock at $17.00 per share once the options vest and before their August 3, 2036 expiration.
How many Attovia Therapeutics (ATTO) options did Mitchell Gold receive?
Mitchell Gold received 27,000 stock options for Attovia Therapeutics common stock. All 27,000 options are reported as directly owned following the transaction, subject to the specified vesting schedule through August 4, 2027 and the subsequent 36 months.
What is the vesting schedule for Mitchell Gold’s ATTO stock options?
The options vest over time: 25% of the 27,000 options vest on August 4, 2027. The remaining options then vest in equal monthly installments over the next 36 months, conditioned on continued service to Attovia Therapeutics.
When do Mitchell Gold’s Attovia Therapeutics stock options expire?
The stock options expire on August 3, 2036. After that date, any unexercised portion of the 27,000 options at the $17.00 exercise price will lapse, assuming they have vested according to the award’s schedule.
Are the ATTO options reported by Mitchell Gold part of a 10b5-1 trading plan?
The filing indicates the Rule 10b5-1 checkbox is not marked, and there is no footnote describing a trading plan. The grant is reported simply as a stock option award subject to time-based vesting and continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
